0001209191-20-049832.txt : 20200909 0001209191-20-049832.hdr.sgml : 20200909 20200909161230 ACCESSION NUMBER: 0001209191-20-049832 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200908 FILED AS OF DATE: 20200909 DATE AS OF CHANGE: 20200909 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Turner Leagh Erin CENTRAL INDEX KEY: 0001746255 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38467 FILM NUMBER: 201166654 MAIL ADDRESS: STREET 1: 228 DOUGLAS DRIVE CITY: TORONTO STATE: A6 ZIP: M4W 2C1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ceridian HCM Holding Inc. CENTRAL INDEX KEY: 0001725057 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 463231686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3311 EAST OLD SHAKOPEE ROAD CITY: MINNEAPOLIS STATE: MN ZIP: 55425 BUSINESS PHONE: 952-853-8100 MAIL ADDRESS: STREET 1: 3311 EAST OLD SHAKOPEE ROAD CITY: MINNEAPOLIS STATE: MN ZIP: 55425 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-08 0 0001725057 Ceridian HCM Holding Inc. CDAY 0001746255 Turner Leagh Erin C/O CERIDIAN HCM HOLDING INC. 3311 EAST OLD SHAKOPEE ROAD MINNEAPOLIS MN 55425 0 1 0 0 President and COO Common Stock 2020-09-08 4 M 0 5000 38.63 A 126611 D Common Stock 2020-09-08 4 S 0 1125 70.37 D 125486 D Common Stock 2020-09-08 4 S 0 3054 71.36 D 122432 D Common Stock 2020-09-08 4 S 0 821 72.62 D 121611 D Option (right to purchase) 38.63 2020-09-08 4 M 0 5000 D 2028-09-04 Common Stock 5000 90000 D Option (right to purchase) 49.93 2029-03-20 Common Stock 76335 76335 D Option (right to purchase) 65.26 2030-05-08 Common Stock 187321 187321 D Performance Units 2021-03-01 Common Stock 3382 3382 D The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.019 to $70.815 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.05 to $71.97 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.08 to $72.87 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 25,000 shares issuable at the election of the recipient pursuant to vested Restricted Stock Units, granted on September 4, 2018, and 25,000 shares issuable pursuant to Restricted Stock Units that vest in two equal annual installments beginning on September 4, 2021, (ii) 50,000 shares that are issuable pursuant to Restricted Stock Units, granted on September 9, 2019, that vest in four equal annual installments beginning on September 9, 2020, (iii) 1,538 shares that are issuable pursuant to Restricted Stock Units, granted on February 28, 2020, that vest in three annual installments beginning on February 28, 2021, and (iv) 20,073 shares that are issuable pursuant to Restricted Stock Units, granted on May 8, 2020, that vest in three annual installments beginning on May 8, 2021. Consists of 45,000 vested and exercisable options as of September 4, 2020, of which 5,000 are being exercised pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, and 50,000 options that vest and become exercisable in two equal annual installments beginning on September 4, 2021. Not applicable. Consists of 19,083 vested and exercisable options as of March 20, 2020 and 57,252 options that vest and become exercisable in three annual installments beginning on March 20, 2021. These options vest and become exercisable in four annual installments beginning on May 8, 2021. Each performance unit, granted on February 28, 2020, represents a contingent right to receive up to 1.25 shares of Common Stock. The performance units vest upon satisfaction of Cloud Revenue and Adjusted EBITDA margin targets under the Company's 2020 Management Incentive Plan. For Leagh Turner pursuant to the Power of Attorney previously filed. /s/ William E. McDonald, attorney-in-fact 2020-09-09